{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:10:02Z","timestamp":1789053002244,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> Surgical exposure of groin vessels to establish cardiopulmonary bypass (CPB) for minimally-invasive valve surgery (MIS) is standard of care but may result in postoperative wound healing disorders or seroma formation. Therefore, adaption of transcatheter techniques for fully percutaneous insertion of CPB cannulae may improve clinical results. We herein analyze a single center experience with a novel plug-based vascular closure device for MIS.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Between 03\/2020 and 02\/2021 MIS using the MANTA\u2122 (Teleflex Medical Inc., Wayne, PA, USA) vascular closure device was performed in 28 consecutive patients (58.8 \u00b1 10.6 years, 60.3% male, logEuroSCORE II 1.1 \u00b1 0.8%) receiving mitral and\/or tricuspid valve repair\/replacement. Concomitant procedures were left atrial appendage occlusion and cryoablation for atrial fibrillation in 21.4% (6\/28) and 10.7% (3\/28) of patients, respectively. Data were retrospectively analyzed in accordance with standardized M-VARC definitions. MANTA\u2122 device success and early safety was defined as absence of any access site or access related vascular injury and major and life-threatening bleeding complications.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> MANTA\u2122 device success with immediate hemostasis and early safety were 96.4% (27\/28). In one case, device failure necessitated surgical cut down without further complications. Mean aortic cross clamp time and cardiopulmonary bypass were 96.5 \u00b1 24.2 min and 150.2 \u00b1 33.6 min. Stroke, renal failure or myocardial infarction were not observed. Intensive care unit and total hospital stay were 1.7 \u00b1 0.8 days and 10.1 \u00b1 5.7 days. Overall 30-day mortality was 0%. Post-procedure echocardiography presented one case of residual moderate tricuspid regurgitation and competent valves in all other cases.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The MANTA\u2122 device is safe and effective in MIS. Its ease of use and effectiveness to achieve immediate hemostasis have further simplified MIS.<\/jats:p>","DOI":"10.3389\/fcvm.2021.682321","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T06:30:16Z","timestamp":1626849016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A Novel Plug-Based Vascular Closure Device for Percutaneous Femoral Artery Closure in Patients Undergoing Minimally-Invasive Valve Surgery"],"prefix":"10.3389","volume":"8","author":[{"given":"Andreas","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Sarwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenard","family":"Conradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1067\/mtc.2003.406","article-title":"Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients","volume":"125","author":"David","year":"2003","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jtcvs.2019.08.006","article-title":"Long-term outcomes of chordal replacement with expanded polytetrafluoroethylene sutures to repair mitral leaflet prolapse","volume":"160","author":"David","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0039-1693022","article-title":"German heart surgery report 2018: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery","volume":"67","author":"Beckmann","year":"2019","journal-title":"Thorac Cardiovasc Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/1556984519887946","article-title":"Endoscopic tricuspid valve surgery is a safe and effective option","volume":"15","author":"Abdelbar","year":"2020","journal-title":"Innovations (Phila)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1055\/s-0039-1700506","article-title":"Concomitant tricuspid valve repair during minimally invasive mitral valve repair","volume":"68","author":"Pfannmueller","year":"2020","journal-title":"Thorac Cardiovasc Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e001393","DOI":"10.1136\/openhrt-2020-001393","article-title":"Minimally invasive mitral valve surgery: a systematic safety analysis","volume":"7","author":"Ko","year":"2020","journal-title":"Open Heart."},{"key":"B7","first-page":"739","article-title":"Total percutaneous femoral vessels cannulation for minimally invasive mitral valve surgery","volume":"2","author":"Pozzi","year":"2013","journal-title":"Ann Cardiothorac Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.21037\/jtd.2019.12.126","article-title":"Totally endoscopic mitral valve repair using a three-dimensional endoscope system: initial clinical experience in Korea","volume":"12","author":"Kim","year":"2020","journal-title":"J Thorac Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ccd.29439","article-title":"Dedicated plug based closure for large bore access -The MARVEL prospective registry","volume":"97","author":"Kroon","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/1556984520956300","article-title":"The MANTA vascular closure device for percutaneous femoral vessel cannulation in minimally invasive surgical mitral valve repair","volume":"15","author":"Van Praet","year":"2020","journal-title":"Innovations (Phila)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S0735","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Otto","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/ejcts\/ezw184","article-title":"A matched pairs analysis of non-rib-spreading, fully endoscopic, mini-incision technique versus conventional mini-thoracotomy for mitral valve repair","volume":"50","author":"Westhofen","year":"2016","journal-title":"Eur J Cardiothorac Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00392-018-1407-z","article-title":"Transaxillary transcatheter aortic valve implantation utilizing a novel vascular closure device with resorbable collagen material: a feasibility study","volume":"108","author":"Schaefer","year":"2019","journal-title":"Clin Res Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/eurheartj\/ehv333","article-title":"Mitral Valve Academic Research Consortium (MVARC). Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium","volume":"66","author":"Stone","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jacc.2018.01.065","article-title":"GARY executive board. rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis","volume":"71","author":"Ensminger","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B16","first-page":"2020","article-title":"Catheter-based cerebral protection system in open cardiac surgery: An example of true hybrid surgery","volume":"22","author":"Capestro","year":"2020","journal-title":"Multimed Man Cardiothorac Surg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ejcts.2010.06.022","article-title":"Percutaneous femoral artery access with Prostar device for innovative mitral and aortic interventions","volume":"39","author":"Vergnat","year":"2011","journal-title":"Eur J Cardiothorac Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1510\/icvts.2010.263715","article-title":"Total percutaneous cardiopulmonary bypass with Perclose ProGlide","volume":"13","author":"Ramponi","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1708538120965310","DOI":"10.1177\/1708538120965310","article-title":"Comparison between PeRcutanEous and surgical femoral aCcess for endovascuLar aOrtic repair in patientS with typE III aortic Dissection (PRECLOSE Trial)","volume":"14","author":"Sahin","year":"2020","journal-title":"Vascular."},{"key":"B20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ejvs.2010.02.001","article-title":"Percutaneous access for endovascular aneurysm repair: a systematic review","volume":"39","author":"Malkawi","year":"2010","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.athoracsur.2019.10.038","article-title":"Percutaneous vascular closure device in minimally invasive mitral valve surgery","volume":"110","author":"Kastengren","year":"2020","journal-title":"Ann Thorac Surg."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718773.","article-title":"First experiences with manta vascular closure device in minimally invasive valve surgery","author":"Ahmad","year":"2020","journal-title":"Thorac Cardiovasc Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e007258","DOI":"10.1161\/CIRCINTERVENTIONS.119.007258","article-title":"SAFE MANTA study investigators. pivotal clinical study to evaluate the safety and effectiveness of the manta percutaneous vascular closure device","volume":"12","author":"Wood","year":"2019","journal-title":"Circ Cardiovasc Interv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/ccd.27595","article-title":"Impact of percutaneous femoral arteriotomy closure using the MANTA TM device on vascular and bleeding complications after transcatheter aortic valve replacement","volume":"92","author":"De Palma","year":"2018","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.682321\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T06:30:21Z","timestamp":1626849021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.682321\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":24,"alternative-id":["10.3389\/fcvm.2021.682321"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.682321","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"article-number":"682321"}}